analytica-word.com

Current News

Country:
Operation:
Search for:
Overview Companies Countries
All   Business   Career   Cooperation   Finances   Laws   Manufacturing   Market
People   Politics   Price Development   Products   Research   Technology

Print version | PDF version | Send article | RSS-FeedRSS-Feed

Sigma-Aldrich, Oxford BioMedica and Open Biosystems Settle Patent Dispute Over Use of LentiVector Technology in Research Reagent

11 Mar 2008 - Sigma-Aldrich, Oxford BioMedica and Open Biosystems, Inc. have jointly announced a confidential settlement of their patent litigation. Sigma-Aldrich and Oxford BioMedica agreed to dismiss the lawsuit brought against Open Biosystems. Open Biosystems agreed to dismiss its counterclaims in the lawsuit. As part of the settlement Open Biosystems will acquire certain license rights under the Oxford BioMedica patents for use of the LentiVector technology in research activities. Other details of the agreement have not been disclosed.
 
Additional information

Open Biosystems, Inc.
Huntsville, United States of America

News
-  02 Jul 2008 - Thermo Fisher Scientific acquires Open Biosystems
 

Oxford BioMedica plc
Oxford, United Kingdom

News
-  26 Apr 2006 - Sigma-Aldrich Initiates RNAi Partnership Program
 
Newsletter Subscription
Your e-mail:
Top  
© 2007-2008 Messe München GmbH